TickerFactsScreenerDevelopers

Lyell Immunopharma, Inc. (LYEL) — Net Income

Annual figures by fiscal year, from SEC filings.

2019: -$129.38M2020: -$204.47M2021: -$250.22M2022: -$183.12M2023: -$234.63M2024: -$342.99M2025: -$274.45M-$274.45M
2019Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$274.45M+20.0%
2024-$342.99M-46.2%
2023-$234.63M-28.1%
2022-$183.12M+26.8%
2021-$250.22M-22.4%
2020-$204.47M-58.0%
2019-$129.38M—